Citigroup’s Corbus Pharmaceuticals CRBP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.4K | Sell |
1,657
-6,641
| -80% | -$45.8K | ﹤0.01% | 4429 |
|
|
2025
Q1 | $44.1K | Sell |
8,298
-912
| -10% | -$4.84K | ﹤0.01% | 4140 |
|
|
2024
Q4 | $109K | Buy |
9,210
+1,726
| +23% | +$20.4K | ﹤0.01% | 3955 |
|
|
2024
Q3 | $154K | Buy |
7,484
+3,101
| +71% | +$64K | ﹤0.01% | 3765 |
|
|
2024
Q2 | $198K | Sell |
4,383
-10,924
| -71% | -$494K | ﹤0.01% | 3159 |
|
|
2024
Q1 | $601K | Buy |
15,307
+14,741
| +2,604% | +$578K | ﹤0.01% | 2736 |
|
|
2023
Q4 | $3.42K | Buy |
+566
| New | +$3.42K | ﹤0.01% | 4586 |
|
|
2021
Q4 | – | Sell |
-3
| Closed | – | – | 5047 |
|
|
2021
Q3 | $0 | Sell |
3
-384
| -99% | – | ﹤0.01% | 5052 |
|
|
2021
Q2 | $21K | Sell |
387
-169
| -30% | -$9.17K | ﹤0.01% | 4588 |
|
|
2021
Q1 | $33K | Sell |
556
-505
| -48% | -$30K | ﹤0.01% | 4281 |
|
|
2020
Q4 | $40K | Sell |
1,061
-1,124
| -51% | -$42.4K | ﹤0.01% | 4231 |
|
|
2020
Q3 | $118K | Sell |
2,185
-536
| -20% | -$28.9K | ﹤0.01% | 3045 |
|
|
2020
Q2 | $685K | Buy |
2,721
+524
| +24% | +$132K | ﹤0.01% | 2356 |
|
|
2020
Q1 | $345K | Sell |
2,197
-953
| -30% | -$150K | ﹤0.01% | 2510 |
|
|
2019
Q4 | $516K | Buy |
3,150
+1,723
| +121% | +$282K | ﹤0.01% | 2615 |
|
|
2019
Q3 | $208K | Sell |
1,427
-104
| -7% | -$15.2K | ﹤0.01% | 3071 |
|
|
2019
Q2 | $318K | Sell |
1,531
-443
| -22% | -$92K | ﹤0.01% | 2952 |
|
|
2019
Q1 | $411K | Buy |
1,974
+103
| +6% | +$21.4K | ﹤0.01% | 2635 |
|
|
2018
Q4 | $329K | Sell |
1,871
-199
| -10% | -$35K | ﹤0.01% | 2794 |
|
|
2018
Q3 | $469K | Buy |
2,070
+594
| +40% | +$135K | ﹤0.01% | 2582 |
|
|
2018
Q2 | $224K | Buy |
1,476
+343
| +30% | +$52.1K | ﹤0.01% | 2872 |
|
|
2018
Q1 | $207K | Buy |
1,133
+392
| +53% | +$71.6K | ﹤0.01% | 2915 |
|
|
2017
Q4 | $158K | Buy |
741
+656
| +772% | +$140K | ﹤0.01% | 3125 |
|
|
2017
Q3 | $18K | Buy |
85
+75
| +750% | +$15.9K | ﹤0.01% | 4035 |
|
|
2017
Q2 | $2K | Sell |
10
-43
| -81% | -$8.6K | ﹤0.01% | 4528 |
|
|
2017
Q1 | $13K | Buy |
+53
| New | +$13K | ﹤0.01% | 4215 |
|